---
title: "Cogent Biosciences (COGT.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/COGT.US/norm.md"
symbol: "COGT.US"
name: "Cogent Biosciences"
parent: "https://longbridge.com/zh-CN/quote/COGT.US.md"
datetime: "2026-05-20T18:49:43.781Z"
locales:
  - [en](https://longbridge.com/en/quote/COGT.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/COGT.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/COGT.US/norm.md)
---

# Cogent Biosciences (COGT.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.6000 | -0.6829 | -0.5880 | -0.6419 | -0.6349 |
| ROE | -71.46% | -110.57% | -267.90% | -372.41% | -224.50% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -97.35M | -102.49M | -80.93M | -73.53M | -71.99M |
| 营业利润 | -103.61M | -99.49M | -83.36M | -75.58M | -74.93M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 903.01M | 937.61M | 425.93M | 274.82M | 283.80M |
| 权益乘数 | 1.49 | 1.47 | 1.41 | 1.77 | 1.30 |
| 每股净资产 | 3.18 | 3.40 | 1.39 | 0.4133 | 0.9728 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 866.38M | 900.76M | 390.89M | 237.85M | 245.66M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 22.85M | 23.54M | 23.86M | 24.95M | 26.05M |
| 净债务 | -627.73M | -661.97M | -330.33M | -177.19M | -228.57M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -86.88M | -79.11M | -64.29M | -54.54M | -66.51M |
| 投资现金流 | -36.46M | -322.77M | -155.05M | 8.91M | 69.38M |
| 融资现金流 | 52.54M | 588.67M | 217.37M | 47.23M | 24.97M |
| 自由现金流 | -54.78M | -47.47M | -35.83M | -27.38M | -40.50M |
| 现金流充裕率 | -19350.33% | -142.67% | 3207.88% | -2479.18% | -12159.23% |
| 举债与偿债 | - | 223.10M | 0.0000 | 49.29M | - |
| 资本支出 | -449000.00 | -811000.00 | -65000.00 | -131000.00 | -547000.00 |